Ironwood Pharmaceuticals | IRWD - Текущие активы





Текущие активы Изменить Дата
Acadia Pharmaceuticals USD 1.27B 43.88M 2026-09
Agios Pharmaceuticals USD 752.1M 34.43M 2026-09
Akebia Therapeutics USD 220.78M 8.77M 2026-09
Almirall EUR 747.1M 33.12M 2026-06
Alnylam Pharmaceuticals USD 5.11B 492.49M 2026-09
Amarin USD 612.88M 10.12M 2026-09
Ardelyx USD 441.39M 538K 2026-09
Astellas Pharma JPY 1.44T 41.22B 2026-09
AstraZeneca USD 31.45B 3.48B 2026-09
Charles River Laboratories USD 1.54B 5.92M 2026-09
Coherus Biosciences USD 133.79M 72.25M 2026-06
Emergent BioSolutions USD 679.5M 41.3M 2023-12
Halozyme Therapeutics USD 1.85B 913.71M 2026-09
Incyte USD 5.52B 505.2M 2026-09
Ironwood Pharmaceuticals USD 225.99M 26.79M 2026-09
Karyopharm Therapeutics USD 126.33M 23.19M 2026-03
Lexicon Pharmaceuticals USD 186.03M 84.14M 2026-03
MacroGenics USD 295.08M 26.61M 2026-09
Moderna USD 7.34B 1.53B 2026-09
Myriad Genetics USD 289M 23.8M 2026-06
Pacira USD 10.3B 9.68B 2026-09
PTC Therapeutics USD 2.54B 79.58M 2026-09
Puma Biotechnology USD 143.58M 7M 2025-09
Sarepta Therapeutics USD 2.27B 49.06M 2026-09
Takeda JPY 3T 153.11B 2026-09
Ultragenyx Pharmaceutical USD 544M 62M 2026-09
Vanda Pharmaceuticals USD 347.26M 20.23M 2025-12